Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

June 17, 1997

IND for gene therapy for cystic fibrosis approved

June 13, 1997

NIH funds high-throughput screening in allergic inflammation and immunology by Cadus

June 11, 1997

Inflazyme granted Australian patent for antiinflammatory agents

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...